Aesthetic Medicine

Fillers – Hyaluronic Acid (HA)

Hyaluronic acid was first used in medicine in mid 1980s. Currently, HA is the world’s most frequently used filler. It is among the natural chemical substances found in the skin and serves as a major structural component of extracellular space. When used in aesthetic medicine, hyaluronic acid is cross-linked which means it is subjected to a process aimed at prolonging its residence time in tissue.

The use of hyaluronic acid in aesthetic medicine is safe and produces satisfactory results. Techniques for filling wrinkles with treatments based on the use of botulinum toxin allow you to get the effect of a significant improvement in the appearance of facial skin without the need for surgical intervention.

What does the treatment with HA fillers involve?

Hyaluronic acid is used as a static facial wrinkle filler. Clinical effects start becoming noticeable within 24-48 h and the maximum effect occurs after 2 approximately weeks and lasts from 6 to 12 months. During this period, the filler is gradually degraded to carbon dioxide and water.

Hyaluronic acid – facial wrinkles correction

  • vertical wrinkles of the glabella area
  • nasolabial folds
  • marionette lines
  • vertical wrinkles of the upper lip

Gyaluronic acid – mesolift

Mesolift is a method for facial skin rejuvenation using non-cross-linked hyaluronic acid. It is performed by numerous superficial needle insertions with a simultaneous injections on non-stabilized hyaluronic acid. Released from deposits, it significantly improves the hydration of the epidermis and gives the skin a radiant look.
Depending on the condition of the skin, 3-4 treatments need to be performed every 2 weeks, then 3 treatments every month and then follow-up treatments every 3-6 months.

Contraindications for HA fillers

  • use of anticoagulation medications or antiplatelet drugs (aspirin, acetylsalicylic acid, Sintrom, Acenokumarol, Plavix; Fraxiparyna, Clexane, Heparyna);
  • use of pain medication up to 2 days prior to treatment;
  • history of severe allergic reactions;
  • implants of breasts, muscles, bones;
  • poor healing of wounds, hypertrophic scars, keloids;
  • active inflammation on the planned treatment area;
  • active diseases with Koebner’s phenomenon (psoriasis, lichen planus);
  • herpes;
  • planned significant activity of the patient within 72 hours following treatment;
  • unrealistic expectations of the patient

Complications after using HA fillers

  • haematomas at the injection site;
  • swellings at the injection site;
  • granulomas;
  • necrosis;
  • allergic reactions.